Tokyo Tape
Sign in
← baby calendar

Annual report

7363.TEDINET S100YNQ1
Period2025-01-01 → 2025-12-31
Filed2026-06-30
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed

Amended by S100YX4F (2026-08-17).

Key figures · 84
MetricValuePeriodScopeSource row
Revenue¥1.9bn2025-01-01 → 2025-12-31StandaloneNet sales
Revenue¥1.5bn2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥1.2bn2023-01-01 → 2023-12-31vStandaloneNet sales (5-year summary)
Revenue¥1.1bn2022-01-01 → 2022-12-31vStandaloneNet sales (5-year summary)
Revenue¥1.0bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Operating income¥214m2025-01-01 → 2025-12-31StandaloneOperating income
Operating income¥46m2024-01-01 → 2024-12-31StandaloneOperating income
Ordinary income¥205m2025-01-01 → 2025-12-31StandaloneOrdinary income
Ordinary income¥44m2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income−¥27m2023-01-01 → 2023-12-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥37m2022-01-01 → 2022-12-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥116m2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥85m2025-01-01 → 2025-12-31StandaloneIncome before income taxes
Profit before tax−¥44m2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Net income¥45m2025-01-01 → 2025-12-31StandaloneProfit loss
Net income−¥15m2024-01-01 → 2024-12-31StandaloneProfit loss
Net income−¥100m2023-01-01 → 2023-12-31vStandaloneNet income loss (5-year summary)
Net income¥21m2022-01-01 → 2022-12-31vStandaloneNet income loss (5-year summary)
Net income¥75m2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Total assets¥1.8bnat 2025-12-31StandaloneAssets
Total assets¥1.5bnat 2024-12-31StandaloneAssets
Total assets¥1.0bnat 2023-12-31vStandaloneTotal assets (5-year summary)
Total assets¥1.1bnat 2022-12-31vStandaloneTotal assets (5-year summary)
Total assets¥1.4bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥1.1bnat 2025-12-31StandaloneLiabilities
Total liabilities¥854mat 2024-12-31StandaloneLiabilities
Net assets / equity¥728mat 2025-12-31StandaloneNet assets
Net assets / equity¥673mat 2024-12-31StandaloneNet assets
Net assets / equity¥706mat 2023-12-31vStandaloneNet assets
Net assets / equity¥806mat 2022-12-31vStandaloneNet assets (5-year summary)
Net assets / equity¥872mat 2021-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥720mat 2025-12-31StandaloneCash and deposits
Cash and deposits¥394mat 2024-12-31StandaloneCash and deposits
Cash & equivalents¥720mat 2025-12-31StandaloneCash and cash equivalents
Cash & equivalents¥394mat 2024-12-31StandaloneCash and cash equivalents
Cash & equivalents¥357mat 2023-12-31vStandaloneCash and cash equivalents
Cash & equivalents¥716mat 2022-12-31vStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.0bnat 2021-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥267m2025-01-01 → 2025-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥195m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥14m2023-01-01 → 2023-12-31vStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥3m2022-01-01 → 2022-12-31vStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥96m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥68m2025-01-01 → 2025-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥599m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥290m2023-01-01 → 2023-12-31vStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥134m2022-01-01 → 2022-12-31vStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥17m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥132m2025-01-01 → 2025-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥285m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥55m2023-01-01 → 2023-12-31vStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥189m2022-01-01 → 2022-12-31vStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥726m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥502025-01-01 → 2025-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-16.462024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-111.172023-01-01 → 2023-12-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥22.942022-01-01 → 2022-12-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥87.662021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥49.232025-01-01 → 2025-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥22.42022-01-01 → 2022-12-31vStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥78.912021-01-01 → 2021-12-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥805.3at 2025-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥755.32at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥783.42at 2023-12-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥893.39at 2022-12-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥955.38at 2021-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio39.8%at 2025-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio44.1%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio69.2%at 2023-12-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio71.3%at 2022-12-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio64.2%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE6.4%2025-01-01 → 2025-12-31StandaloneRate of return on equity (5-year summary)
ROE2.5%2022-01-01 → 2022-12-31vStandaloneRate of return on equity (5-year summary)
ROE12.3%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued941,700at 2025-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued941,700at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued941,700at 2023-12-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued941,700at 2022-12-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued912,200at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees74at 2025-12-31StandaloneNumber of employees
Employees74at 2024-12-31StandaloneNumber of employees
Employees71at 2023-12-31vStandaloneNumber of employees
Employees56at 2022-12-31vStandaloneNumber of employees
Employees49at 2021-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 40
SegmentItemPeriodValue
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentcapex2025-01-01 → 2025-12-31¥200,000
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentdepreciation2025-01-01 → 2025-12-31¥2m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentemployeesat 2025-12-3119 pure
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentrevenue2025-01-01 → 2025-12-31¥289m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentrevenue external2025-01-01 → 2025-12-31¥289m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentsegment assetsat 2025-12-31¥102m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentsegment profit2025-01-01 → 2025-12-31¥19m
Media Business For Pregnancy Childbirth And Childcarereportable segmentcapex2025-01-01 → 2025-12-31¥34m
Media Business For Pregnancy Childbirth And Childcarereportable segmentdepreciation2025-01-01 → 2025-12-31¥54m
Media Business For Pregnancy Childbirth And Childcarereportable segmentemployeesat 2025-12-3149 pure
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue2025-01-01 → 2025-12-31¥1.6bn
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue external2025-01-01 → 2025-12-31¥1.6bn
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue intersegment2025-01-01 → 2025-12-31¥2m
Media Business For Pregnancy Childbirth And Childcarereportable segmentsegment assetsat 2025-12-31¥896m
Media Business For Pregnancy Childbirth And Childcarereportable segmentsegment profit2025-01-01 → 2025-12-31¥466m
Total Of Reportable Segments And Otherssegment totalcapex2025-01-01 → 2025-12-31¥35m
Total Of Reportable Segments And Otherssegment totaldepreciation2025-01-01 → 2025-12-31¥56m
Total Of Reportable Segments And Otherssegment totalrevenue2025-01-01 → 2025-12-31¥1.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-01-01 → 2025-12-31¥1.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2025-01-01 → 2025-12-31¥2m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2025-12-31¥998m
Total Of Reportable Segments And Otherssegment totalsegment profit2025-01-01 → 2025-12-31¥485m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentcapex2024-01-01 → 2024-12-31¥6m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentdepreciation2024-01-01 → 2024-12-31¥4m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentrevenue2024-01-01 → 2024-12-31¥283m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentrevenue external2024-01-01 → 2024-12-31¥283m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentsegment assetsat 2024-12-31¥72m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentsegment profit2024-01-01 → 2024-12-31−¥4m
Media Business For Pregnancy Childbirth And Childcarereportable segmentcapex2024-01-01 → 2024-12-31¥563m
Media Business For Pregnancy Childbirth And Childcarereportable segmentdepreciation2024-01-01 → 2024-12-31¥48m
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue2024-01-01 → 2024-12-31¥1.2bn
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue external2024-01-01 → 2024-12-31¥1.2bn
Media Business For Pregnancy Childbirth And Childcarereportable segmentsegment assetsat 2024-12-31¥1.0bn
Media Business For Pregnancy Childbirth And Childcarereportable segmentsegment profit2024-01-01 → 2024-12-31¥344m
Total Of Reportable Segments And Otherssegment totalcapex2024-01-01 → 2024-12-31¥568m
Total Of Reportable Segments And Otherssegment totaldepreciation2024-01-01 → 2024-12-31¥52m
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-12-31¥1.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-12-31¥1.5bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2024-12-31¥1.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-12-31¥341m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 907
ItemContextValueUnit
Shareholding ratioCurrentYearInstant_No10MajorShareholdersMember0.0134
Number of shares heldCurrentYearInstant555568
Shareholding ratioCurrentYearInstant0.6235
Number of shares issued shares voting rightsCurrentYearInstant_SharesWithNoVotingRightsMember－
Number of shares issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of voting rights issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember50900
Number of voting rights issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember8889
Number of shares issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember888900
Number of shares issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember1900
Number of shares issued shares voting rightsCurrentYearInstant941700
Number of voting rights issued shares voting rightsCurrentYearInstant8889
Number of shares held in own name treasury shares etcCurrentYearInstant_Row1Member50900
Number of shares held in others names treasury shares etcCurrentYearInstant_Row1Member－
Total number of shares held treasury shares etcCurrentYearInstant_Row1Member50900
Shareholding ratio treasury shares etcCurrentYearInstant_Row1Member0.0541
Number of shares held in own name treasury shares etcCurrentYearInstant50900
Number of shares held in others names treasury shares etcCurrentYearInstant－
Total number of shares held treasury shares etcCurrentYearInstant50900
Shareholding ratio treasury shares etcCurrentYearInstant0.0541
Number of male directors and other officersFilingDateInstant7
Number of female directors and other officersFilingDateInstant1
Ratio of female directors and other officersFilingDateInstant0.125
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E36431-000YasudaKeijiMember201500
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E36431-000FukushimaTomoharuMember21500
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E36431-000SasakiKazuyukiMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E36431-000MiyakeHidekiMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E36431-000TakahashiShizuyoMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E36431-000KuroiwaDaisukeMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E36431-000MineoAkihiraMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E36431-000KatayamaTomohiroMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant223000
Audit fees reporting companyPrior1YearDuration23800000JPY
Non audit fees reporting companyPrior1YearDuration－JPY
Audit fees reporting companyCurrentYearDuration47980000JPY
Non audit fees reporting companyCurrentYearDuration－JPY
Total amount of remuneration etc remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingOutsideDirectorsMember63100000JPY
Fixed remuneration remuneration by category of directors and other officersCurrentYearDuration_DirectorsExcludingOutsideDirectorsMember63100000JPY
Performance based remuneration remuneration by category of directors and other officersCurrentYearDuration_DirectorsExcludingOutsideDirectorsMember－JPY
Retirement benefits remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingOutsideDirectorsMember－JPY
Number of directors and other officers remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingOutsideDirectorsMember4
Total amount of remuneration etc remuneration etc by category of directors and other officersCurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember3000000JPY
Fixed remuneration remuneration by category of directors and other officersCurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember3000000JPY
Performance based remuneration remuneration by category of directors and other officersCurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember－JPY
Retirement benefits remuneration etc by category of directors and other officersCurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember－JPY
Number of directors and other officers remuneration etc by category of directors and other officersCurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember1
Total amount of remuneration etc remuneration etc by category of directors and other officersCurrentYearDuration_OutsideDirectorsAndOtherOfficersMember7800000JPY
Fixed remuneration remuneration by category of directors and other officersCurrentYearDuration_OutsideDirectorsAndOtherOfficersMember7800000JPY
Performance based remuneration remuneration by category of directors and other officersCurrentYearDuration_OutsideDirectorsAndOtherOfficersMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2024-12-31pass rounding
balance sheet identitynon_consolidated 2025-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2025-12-31pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · operating cash flownon_consolidated 2025-01-01/2025-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2025-01-01/2025-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2025-12-31pass